AI joins the quest to find new treatments for rare diseases

Belgian AI company Kantify was doing business as usual until a cancer diagnosis forced the team to rethink their direction. “We built algorithms for sectors like marketing or transport,” said Ségolène Martin, Kantify’s co-founder and CEO. “Those were complex projects that had nothing to do with health, but they enabled us to build a deep